Lisa Guo
Pfizer (United States)(US)
Publications by Year
Research Areas
Protein Kinase Regulation and GTPase Signaling, PI3K/AKT/mTOR signaling in cancer, Bone Tissue Engineering Materials, Synthesis and biological activity, Pharmacogenetics and Drug Metabolism
Most-Cited Works
- → Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design(2012)79 cited
- → Biofunctionalization of titanium with PEG and anti-CD34 for hemocompatibility and stimulated endothelialization(2011)64 cited
- → Discovery of Pyrroloaminopyrazoles as Novel PAK Inhibitors(2012)60 cited
- → Abstract PR-2: Discovery of p21-activated kinase inhibitor PF-03758309(2009)2 cited
- → Abstract 5779: The discovery of the potent and selective PI3K/mTOR dual inhibitor PF-04691502 through structure-based drug design(2010)